Dishman Carbogen Amcis Quarterly Results for Trading Insights

DCAL • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹65 Cr
QSept 2025
Quarterly Results

Dishman Carbogen Amcis Quarterly Results Key Highlights

  • Revenue of ₹661 Cr in Sept 2025 (-8.7% vs Mar 2025, -17.0% vs Sept 2024)
  • Net Profit of ₹65 Cr in Sept 2025 (+51.2% vs Mar 2025, +97.0% vs Sept 2024)
  • EBITDA of ₹157 Cr in Sept 2025 (+5.4% vs Mar 2025)
  • Operating Margin of 23.0% in Sept 2025 (+3.0pp vs Mar 2025)
  • Earnings Per Share of ₹4.16 in Sept 2025 (+51.3% vs Mar 2025)

Dishman Carbogen Amcis Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 661 724 733 727 796 -8.7% -17.0%
Net Profit (₹ Cr) 65 43 23 -13 33 - -
EBITDA (₹ Cr) 157 149 163 120 151 - -
EPS (₹) 4.16 2.75 1.49 -0.83 2.11 - -
Operating Margin (%) 23.0% 20.0% 19.0% 16.0% 18.0% - -

Dishman Carbogen Amcis Share Price Trend Around Quarterly Results

Visualize Dishman Carbogen Amcis's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Dishman Carbogen Amcis

Additional stock information and data for DCAL

DCAL stock price BSE
DCAL earnings valuation
DCAL yearly price range

Profitability Ratios

Profit Margin 9.8%
EBITDA Margin 23.8%
Operating Margin 23.0%
ROE (Annual) 4.5%

Balance Sheet Highlights

Total Assets ₹9,999 Cr
Total Equity ₹5,832 Cr
Current Assets ₹2,200 Cr
Current Liabilities ₹2,243 Cr

Cash Flow Analysis

Operating Cash Flow ₹375 Cr
Investing Cash Flow ₹-196 Cr
Financing Cash Flow ₹-102 Cr
Net Cash Flow ₹77 Cr

Current Market Data

Current Price ₹150.72
Exchange NSE
Last Updated Apr 07, 2026

Revenue Trend (₹ Cr)

Dec 2025 727
Jun 2025 733
Mar 2025 724
Sept 2025 661

Net Profit Trend (₹ Cr)

Dec 2025 -13
Jun 2025 23
Mar 2025 43
Sept 2025 65

Operating Margin Trend (%)

Dec 2025 16.0%
Jun 2025 19.0%
Mar 2025 20.0%
Sept 2025 23.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Dishman Carbogen Amcis quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1718.0 14,875 3,125 +10.8% - 21.0% 132.2
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5850.0 2,860 689 +7.1% - 24.1% 225.3
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4051.3 3,219 591 +11.3% - 18.4% 231.0
Lupin
Sept 2025 		₹102,578.78 Cr 2298.3 6,921 1,485 +23.2% - 21.5% 71.0
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1196.1 9,135 1,337 +1.1% - 14.6% 73.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores